Adjunct Associate Professor of Neurology, Adjunct Assistant Professor of Medicine, Johns Hopkins University School of Medicine

Neurology

Doctor Andrew Mammen, MD works in the field of Neurology. He went to medical school at Johns Hopkins University School of Medicine. Johns Hopkins University School of Medicine is a top medical university. Johns Hopkins University School of Medicine has a rank of 3 in research and a 29 in primary care He over the years received 1 awards: "CMS Meaningful Use Stage 1 Certification". Andrew Mammen, MD is a published physician as well. He has 38 publications published. The latest was: Protein phosphorylation of ligand-gated ion channels. He accepts Medicare.

Publications

---

• Intravenous Immune Globulin for Statin-Triggered Autoimmune Myopathy.
• Necrotizing myopathy caused by central hypothyroidism.
• Diagnostic evaluation of rhabdomyolysis.
• Expression of the dermatomyositis autoantigen transcription intermediary factor 1γ in regenerating muscle.
• Laing distal myopathy pathologically resembling inclusion body myositis.
• Brief report: antisynthetase Syndrome-associated myocarditis.
• Necrotizing myopathies: beyond statins.
• Clinical and pathologic differences in interstitial lung Disease based on antisynthetase antibody type.
• Is statin-induced myositis part of the polymyositis Disease spectrum?
• Myopathy in scleroderma, its identification, prevalence, and treatment: lessons learned from cohort studies.
• Most Patients With Cancer-Associated Dermatomyositis Have Antibodies to Nuclear Matrix Protein NXP-2 or Transcription Intermediary Factor 1γ.
• The spectrum of statin myopathy.
• A case of progressive quadriceps weakness and hyperCKemia mimicking inclusion body myositis.
• 1H Magnetic resonance spectroscopy findings in idiopathic Inflammatory myopathies at 3 T: feasibility and first results.
• Statin-associated autoimmune myopathy and anti-HMGCR autoantibodies: A review.
• Antibody levels correlate with creatine kinase levels and strength in anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy.
• Synaptic targeting of glutamate receptors.
• Neurotransmitter release regulated by nitric oxide in PC-12 cells and brain synaptosomes.
• Protein phosphorylation of ligand-gated ion channels.
• Detection of soluble forms of the beta-amyloid precursor protein in human plasma.
• Phosphorylation of the alpha-amino-3-hydroxy-5-methylisoxazole4-propionic acid receptor GluR1 subunit by calcium/calmodulin-dependent kinase II.
• The mouse APLP2 gene. Chromosomal localization and promoter characterization.
• Redistribution and stabilization of cell surface glutamate receptors during synapse formation.
• The development of excitatory synapses in cultured spinal neurons.
• Characterization of Multiple phosphorylation sites on the AMPA receptor GluR1 subunit.
• Interaction of the N-methyl-D-aspartate receptor complex with a novel synapse-associated protein, SAP102.
• A novel conserved isoform of the ubiquitin ligase UFD2a/UBE4B is expressed exclusively in mature striated muscle cells.
• Rarity of anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies in statin users, including those with self-limited musculoskeletal side effects.
• Autoimmune myopathies: autoantibodies, phenotypes and pathogenesis.
• Large quantities of Abeta peptide are constitutively released during amyloid precursor protein metabolism in vivo and in vitro.
• Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy.
• Statin myopathy: a review of recent progress.
• Rituximab therapy for myopathy associated with anti-signal recognition particle antibodies: a case series.
• A novel autoantibody recognizing 200-kd and 100-kd proteins is associated with an immune-mediated necrotizing myopathy.
• Dermatomyositis and Polymyositis: Clinical presentation, autoantibodies, and pathogenesis.
• Expression of the dermatomyositis autoantigen Mi-2 in regenerating muscle.
• The difficulties of diagnosing neuroMuscular complications.

Schools

---

• Johns Hopkins University School of Medicine

Procedures Preformed

---

• EEG (Electroencephalogram)
• EMG (Electromyography)

Conditions Treated

---

• Alzheimer's Disease
• Anterior Horn Disease
• Bell's Palsy
• Carpal Tunnel Syndrome
• View All

Doctors Specialties

---

• Neurology
• Neuromuscular Medicine

Accepted Insurances

---

Awards

---

• CMS Meaningful Use Stage 1 Certification

Education

---

• Johns Hopkins University
• Johns Hopkins University School of Medicine

Hospital

---

• Johns Hopkins Hospital
• Johns Hopkins Bayview Medical Center

Drug Facts

---

NPI NUMBER		1619923786
NPPES Provider LastName		MAMMEN
NPPES Provider FirstName		ANDREW
NPPES Provider ZIPCode		212242735
NPPES Provider State		MD
Specialty Description		Neurology
Total Claim Count		200.0
Distinct Opioid Count		0.0
Opioid Claim Count		0.0
Percent Opioid Claims		0.0

Helpful Reviews

---

Give Anonymous Review

Medicare Facts

---

National Provider Identifier [NPI]	1619923786
Last Name Of The Provider	MAMMEN
First Name Of The Provider	ANDREW
View All

Similar Doctors

---

	Dr. Arun Venkatesan, MD This Doctor is OpenDoctor Recommended.
	Dr. Elisabeth B. Marsh, MD This Doctor is OpenDoctor Recommended.
	Dr. John N. Ratchford, MD This Doctor is OpenDoctor Recommended.
	Dr. Peter H. Gorman, MD This Doctor is OpenDoctor Recommended.
	Dr. Nishiena Gandhi, MD This Doctor is OpenDoctor Recommended.
	Dr. E R. Dorsey, MD
	Dr. Marian Y. Livingston, MD This Doctor is OpenDoctor Recommended.
	Dr. Varun Shandal, MD
	Dr. Diana L. Vargas, MD
	Dr. Bryan R. Smith, MD
	Dr. Joseph J. Sabatino Jr., MD

---

Doctor Directory | TOS | twitter | FB | Angel | blog